Baird Medical Investment

BDMD

----

Current ValuationThe current P/E ratio is -2.09, within the reasonable range, cheaper than 46.36% of the time in the past 1 years, and the industry ranks 99/174, the industry Median -0.89.

-2.09xP/E

Stock price$0.79Earnings per share$-0.38

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-11.62x	141.71%	$12.36B
GKOSUSGlaukos	-50.59x	75.37%	$9.51B
TFXUSTeleflex	-5.10x	118.39%	$5.26B
PLSEUSPulse Biosciences	-44.53x	27.55%	$3.56B
IRTCUSIRhythm	-242.49x	70.88%	$3.38B
BFLYUSButterfly Network	-28.57x	34.41%	$2.14B
AXGNUSAxogen	-63.27x	18.38%	$2.12B
ASSTUSStrive	-2.00x	63.23%	$1.95B
NVCRUSNovocure	-11.15x	1.23%	$1.66B
ATECUSAlphatec	-14.53x	41.67%	$1.60B
KMTSUSKestra Medical Tech	-10.08x	0.94%	$1.51B
DRTSUSAlpha Tau Medical	-13.96x	--	$1.29B
TNDMUSTandem Diabetes	-17.23x	77.60%	$1.09B
IARTUSIntegra LifeSciences	-144.11x	109.42%	$1.04B
AORTUSArtivion	-324.07x	266.67%	$1.03B
PRCTUSPROCEPT BioRobotics	-9.34x	3.47%	$1.03B
ENOVUSEnovis	-0.91x	100.97%	$1.01B
BBNXUSBeta Bionics	-12.57x	11.66%	$917.55M
CBLLUSCeribell	-13.46x	35.15%	$888.45M
QDELUSQuidelOrtho	-0.81x	75.33%	$851.02M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.